Refine by MP, party, committee, province, or result type.

Results 1-7 of 7
Sorted by relevance | Sort by date: newest first / oldest first

Finance committee  My honest answer is there's an incredible amount of potential synergy, and I mean true synergy, where one plus one equals three--funding the gap in transitional research. Now people are focusing on that, and the biggest problem is that you can't go from all of the great basic res

December 7th, 2007Committee meeting

Bob Hindle

Finance committee  We're working with type 1 and type 2. Maybe I could involve Mr. Pacetti in an answer about expecting a cure in five or 10 years. Complications, prevention--the key is a cure. But JDRF will be around funding research for a long time yet.

December 7th, 2007Committee meeting

Bob Hindle

Finance committee  I believe the part you're referring to about what I said later was that this isn't simply research money, first of all. It is to create a clinical trial network--

December 7th, 2007Committee meeting

Bob Hindle

Finance committee  --which is not bricks and mortar, but it's infrastructure in the industry. And yes, that will then be--

December 7th, 2007Committee meeting

Bob Hindle

Finance committee  It definitely does not.

December 7th, 2007Committee meeting

Bob Hindle

Finance committee  Without a doubt. I must admit I am aware that bill was introduced. Personally, I am not very familiar with the content, but the principle will not only give our donors an additional tax benefit, it will also be an enormous help by recognizing charitable donations.

December 7th, 2007Committee meeting

Bob Hindle

Finance committee  Thank you, Mr. Chair and committee members. On behalf of the Juvenile Diabetes Research Foundation, thank you again for the opportunity to speak with you. You have our written proposal, and this afternoon I will touch on some highlights to bring together the illustration of the

December 7th, 2007Committee meeting

Bob Hindle